![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEW NOVEL INSIGHTS INTO PEDIATRIC ALLERGY AND IMMUNOLOGY Free access
Minerva Pediatrica 2020 October;72(5):364-71
DOI: 10.23736/S0026-4946.20.05993-9
Copyright © 2020 EDIZIONI MINERVA MEDICA
lingua: Inglese
An update on biological therapies for pediatric allergic diseases
Riccardo CASTAGNOLI, Maria DE FILIPPO, Martina VOTTO, Alessia MARSEGLIA, Lorenza MONTAGNA, Gian Luigi MARSEGLIA ✉, Amelia LICARI
Department of Pediatrics, Pediatric Clinic, IRCCS San Matteo Polyclinic Foundation, University of Pavia, Pavia, Italy
Allergic diseases represent a global health burden. Patients with allergic diseases may experience disability, reduced quality of life and productivity, emotional distress, and social restrictions, especially in the most severe cases. Current advances in unveiling the pathogenesis of allergic disorders have paved the way for the development of novel therapeutic strategies. Biological drugs have been widely studied in pediatric allergic asthma, with strong evidence of efficacy and safety. Moreover, promising results derive from studies on other conditions such as atopic dermatitis, chronic spontaneous urticaria, and food allergy. This review analyzes recent evidence on the role of biologic therapies for allergic diseases, focusing on the pediatric age.
KEY WORDS: Child; Asthma; Chronic urticaria; Dermatitis, atopic; Food hypersensitivity